Vera Therapeutics (VERA) Other Gross PP&E Adjustments (2020 - 2026)
Vera Therapeutics posted quarterly Other Gross PP&E Adjustments of -$1.8 million for Q1 2026, up 38.04% year-on-year from -$1.3 million in Q1 2025, and up 84.61% on a QoQ basis from -$11.7 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Other Gross PP&E Adjustments data on file, last reported at -$1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 38.04% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$1.8 million (up 38.04% YoY), and the FY2025 full-year result was -$11.7 million, down 52.7% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$1.8 million, up from -$11.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.8 million in Q1 2026 and bottomed at -$11.7 million in Q4 2025.
- The 5-year median for Other Gross PP&E Adjustments is -$4.3 million (2023), against an average of -$4.8 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments tumbled 1134.21%; it then jumped 55.41% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$6.6 million in 2022, then rose by 10.24% to -$5.9 million in 2023, then retreated by 29.63% to -$7.7 million in 2024, then plunged by 52.7% to -$11.7 million in 2025, then soared by 84.61% to -$1.8 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$1.8 million (Q1 2026), -$11.7 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.81 Mn |
| Mar 31, 2026 | -1.81 Mn |
| Dec 31, 2025 | -11.73 Mn |
| Dec 31, 2025 | -11.73 Mn |
| Sep 30, 2025 | -2.04 Mn |
| Sep 30, 2025 | -2.04 Mn |
| Jun 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | -2.47 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | -7.68 Mn |
| Dec 31, 2024 | -7.68 Mn |
| Sep 30, 2024 | -3.92 Mn |
| Sep 30, 2024 | -3.92 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -5.93 Mn |
| Dec 31, 2023 | -5.93 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Jun 30, 2023 | -4.33 Mn |
| Jun 30, 2023 | -4.33 Mn |
| Mar 31, 2023 | -4.80 Mn |
| Mar 31, 2023 | -4.80 Mn |
| Dec 31, 2022 | -6.60 Mn |
| Dec 31, 2022 | -6.60 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Jun 30, 2022 | -5.90 Mn |
| Jun 30, 2022 | -5.90 Mn |
| Mar 31, 2022 | -6.53 Mn |
| Mar 31, 2022 | -6.53 Mn |
| Dec 31, 2021 | -535,000.00 |
| Dec 31, 2021 | -535,000.00 |
| Dec 31, 2020 | -119,000.00 |
| Dec 31, 2020 | -119,000.00 |